Davis Polk is advising the senior management of Strategic Partners, Credit Suisse’s dedicated secondary private equity business, on the sale of Strategic Partners to Blackstone. The transaction, which is subject to customary closing conditions, is expected to close by the end of the third quarter of 2013.

More >>

Paul, Weiss client Oak Hill Advisors. L.P., as portfolio manager of OHA Intrepid Leveraged Loan Fund, Ltd., a cash flow Collateral Loan Obligation (CLO) fund, completed a precedent-setting refinancing transaction in which $318 million of three classes of secured notes issued by the CLO were simultaneously redeemed and refinanced with proceeds from the issuance of new secured notes. The transaction is one of the few CLO refinancings to be completed in the market and allowed the client to obtain a significantly lower cost of capital.

More >>

John R. Hempill, Jack Kiley and MaryJeanette Dee have joined Sheppard, Mullin, Richter & Hampton LLP as partners in the firm’s New York office. Hempill joins as a member of the Corporate practice group from Morrison Foerster, where he was a former co-chair of the Emerging Companies & Venture Capital group. Kiley joins as a member of the Labor and Employment practice group from Kelley Drye & Warren, where he chaired the Labor and Employment practice group. Dee joins as a member of the Business Trial practice group from Richards Kibbe & Orbe, where she was a member of the executive committee. Joining Kiley at Sheppard Mullin from Kelley Drye & Warren is a six-attorney Labor and Employment group.

More >>

Jeffrey S. Held has been recruited by Day Pitney in New York, according to a press release from the law firm.  The real estate partner brings years of legal experience to the new firm, having worked on numerous transactions involving commercial properties.  He has additional experience advising on corporate transactions for private equity sponsors and in financing deals.

More >>

Ropes & Gray is pleased to announce that Jonathan Gill and Robb Tretter are joining the firm as partners in the private equity practice. Messrs. Gill and Tretter are both highly skilled and experienced attorneys and will immediately enhance the firm’s service to clients on transactions involving distressed assets.

More >>

Davis Polk Helps Pinnacle Airlines Gain Confirmation of Its Chapter 11 Plan of Reorganization.

More >>

Paul Hastings, a leading global law firm, announced today that the firm represented RBC Capital Markets and Morgan Stanley Senior Funding, Inc., as joint lead arrangers and joint bookrunners and Royal Bank of Canada, as administrative agent, in connection with $555 million in senior secured credit facilities in favor of Livingston International, a North American provider of customs brokerage services, for the refinancing of certain existing indebtedness of Livingston International.

More >>

On April 15, Willkie client Fidelity National Information Services, Inc. (“FIS”), completed a public offering of $1 billion of 3.5% Senior Notes due 2023 and $250 million of 2.0% Senior Notes due 2018. The offerings represented FIS’s initial entry into the investment grade debt market following recent upgrades by both Moody’s and S&P. The managing underwriters of the offerings were J.P. Morgan, Bank of America Merrill Lynch and Barclays. FIS will use the proceeds to redeem $750 million of 7.625% Notes due 2017 and for general corporate purposes. The deals were preceded by a three-day non-deal roadshow during the week of April 1.

More >>

Davis Polk advised Credit Suisse Securities (USA) LLC, J.P. Morgan Securities LLC and Merrill Lynch, Pierce, Fenner & Smith Incorporated as representatives of the several underwriters in connection with an SEC-registered offering by The Hartford Financial Services Group, Inc. (The Hartford) of $300 million of 4.3% senior notes due 2043.

More >>

Davis Polk advised Merrill Lynch, Pierce, Fenner & Smith Incorporated, Credit Suisse Securities (USA) LLC and Jefferies LLC as representatives of the several underwriters in connection with the SEC-registered follow-on offering of 8,222,500 shares of common stock of Durata Therapeutics, Inc., including 1,072,500 shares from the full exercise of the underwriters’ option to purchase additional shares, for a price to the public of approximately $57.6 million.

More >>